Englewood Hospital’s physician-investigators are currently recruiting research subjects for participation in the following breast oncology clinical trials.
A011801: The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib
Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
NCT #: 04457596
Englewood Health IRB #: E-21-850
More Information (clinicaltrials.gov)